Company Taiwan Bio Therapeutics Co., Ltd

Equities

6892

TW0006892003

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 03:30:00 18/06/2024 am IST 5-day change 1st Jan Change
38.5 TWD -2.28% Intraday chart for Taiwan Bio Therapeutics Co., Ltd +0.79% +12.24%

Business Summary

Taiwan Bio Therapeutics Co Ltd is a Taiwan-based company mainly engaged in the development of new allogeneic stem cell drugs and the provision of contract development and manufacturing organization (CDMO) services. The main products include Chondrochymal for the treatment of degenerative arthritis of the knee, Biochymal for the treatment of difficult non-healing wounds caused by lower extremity ischemia, OmniMSC/TBPCB201 for the treatment of acute myocardial infarction, and MSC-VEGF for the treatment of lower extremity ischemia. The cell processing center (CPC) is engaged in the provision of a full set of CDMO services, process scale-up services, inspection and development services, and quality control commissioned inspection services. The Company mainly operates in Taiwan market.

Managers

Managers TitleAgeSince
Chief Executive Officer - 15/18/15
Director of Finance/CFO - 01/21/01
Chief Operating Officer - 01/18/01
Director/Board Member - 05/22/05
Comptroller/Controller/Auditor - 17/20/17

Members of the board

Members of the board TitleAgeSince
Director/Board Member 71 24/21/24
Director/Board Member - 16/15/16
Chairman - 16/17/16
Director/Board Member - 05/22/05
Director/Board Member - 21/19/21
Director/Board Member - 21/19/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 74,140,400 50,312,790 ( 67.86 %) 0 67.86 %

Company contact information

Taiwan Bio Therapeutics Co., Ltd.

4/F 66 Shengyi 2nd Road

302041, Hsinchu

+

http://www.twbio-thera.com
address Taiwan Bio Therapeutics Co., Ltd(6892)
  1. Stock Market
  2. Equities
  3. 6892 Stock
  4. Company Taiwan Bio Therapeutics Co., Ltd